Covid-19 Impact on Global Drug Safety and Pharmacovigilance Software Market Size, Status and Forecast 2020-2026

July 2020 | 98 pages | ID: C9C25204D52DEN
QYResearch

Abstracts

This report focuses on the global Drug Safety and Pharmacovigilance Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Safety and Pharmacovigilance Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AB cube
• Max Application
• Ennov Solutions Inc
• ArisGlobal
• EXTEDO GmbH
• Online Business Applications Inc
• Oracle Corporation
• Sparta Systems, Inc.
• United BioSource Corporation
• Sarjen Systems

Market segment by Type, the product can be split into

• ADR Reporting
• Drug Safety Audits
• Issue Tracking
• Fully Integrated Software

Market segment by Application, split into

• Pharma & Biotech Companies
• CROs
• BPOs
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Drug Safety and Pharmacovigilance Software status, future forecast, growth opportunity, key market and key players.
• To present the Drug Safety and Pharmacovigilance Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Drug Safety and Pharmacovigilance Software are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug Safety and Pharmacovigilance Software Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Drug Safety and Pharmacovigilance Software Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 ADR Reporting
  1.4.3 Drug Safety Audits
  1.4.4 Issue Tracking
  1.4.5 Fully Integrated Software
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Drug Safety and Pharmacovigilance Software Market Share by Application: 2020 VS 2026
  1.5.2 Pharma & Biotech Companies
  1.5.3 CROs
  1.5.4 BPOs
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Drug Safety and Pharmacovigilance Software Industry Impact
  1.6.1 How the Covid-19 is Affecting the Drug Safety and Pharmacovigilance Software Industry
    1.6.1.1 Drug Safety and Pharmacovigilance Software Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Drug Safety and Pharmacovigilance Software Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Drug Safety and Pharmacovigilance Software Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Drug Safety and Pharmacovigilance Software Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Drug Safety and Pharmacovigilance Software Growth Trends by Regions
  2.2.1 Drug Safety and Pharmacovigilance Software Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Drug Safety and Pharmacovigilance Software Historic Market Share by Regions (2015-2020)
  2.2.3 Drug Safety and Pharmacovigilance Software Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Drug Safety and Pharmacovigilance Software Market Growth Strategy
  2.3.6 Primary Interviews with Key Drug Safety and Pharmacovigilance Software Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Drug Safety and Pharmacovigilance Software Players by Market Size
  3.1.1 Global Top Drug Safety and Pharmacovigilance Software Players by Revenue (2015-2020)
  3.1.2 Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Players (2015-2020)
  3.1.3 Global Drug Safety and Pharmacovigilance Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drug Safety and Pharmacovigilance Software Market Concentration Ratio
  3.2.1 Global Drug Safety and Pharmacovigilance Software Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance Software Revenue in 2019
3.3 Drug Safety and Pharmacovigilance Software Key Players Head office and Area Served
3.4 Key Players Drug Safety and Pharmacovigilance Software Product Solution and Service
3.5 Date of Enter into Drug Safety and Pharmacovigilance Software Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Drug Safety and Pharmacovigilance Software Historic Market Size by Type (2015-2020)
4.2 Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020)
5.2 Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Drug Safety and Pharmacovigilance Software Market Size (2015-2020)
6.2 Drug Safety and Pharmacovigilance Software Key Players in North America (2019-2020)
6.3 North America Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020)
6.4 North America Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Drug Safety and Pharmacovigilance Software Market Size (2015-2020)
7.2 Drug Safety and Pharmacovigilance Software Key Players in Europe (2019-2020)
7.3 Europe Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020)
7.4 Europe Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020)

8 CHINA

8.1 China Drug Safety and Pharmacovigilance Software Market Size (2015-2020)
8.2 Drug Safety and Pharmacovigilance Software Key Players in China (2019-2020)
8.3 China Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020)
8.4 China Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Drug Safety and Pharmacovigilance Software Market Size (2015-2020)
9.2 Drug Safety and Pharmacovigilance Software Key Players in Japan (2019-2020)
9.3 Japan Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020)
9.4 Japan Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Drug Safety and Pharmacovigilance Software Market Size (2015-2020)
10.2 Drug Safety and Pharmacovigilance Software Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020)
10.4 Southeast Asia Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020)

11 INDIA

11.1 India Drug Safety and Pharmacovigilance Software Market Size (2015-2020)
11.2 Drug Safety and Pharmacovigilance Software Key Players in India (2019-2020)
11.3 India Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020)
11.4 India Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Drug Safety and Pharmacovigilance Software Market Size (2015-2020)
12.2 Drug Safety and Pharmacovigilance Software Key Players in Central & South America (2019-2020)
12.3 Central & South America Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020)
12.4 Central & South America Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 AB cube
  13.1.1 AB cube Company Details
  13.1.2 AB cube Business Overview and Its Total Revenue
  13.1.3 AB cube Drug Safety and Pharmacovigilance Software Introduction
  13.1.4 AB cube Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020))
  13.1.5 AB cube Recent Development
13.2 Max Application
  13.2.1 Max Application Company Details
  13.2.2 Max Application Business Overview and Its Total Revenue
  13.2.3 Max Application Drug Safety and Pharmacovigilance Software Introduction
  13.2.4 Max Application Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.2.5 Max Application Recent Development
13.3 Ennov Solutions Inc
  13.3.1 Ennov Solutions Inc Company Details
  13.3.2 Ennov Solutions Inc Business Overview and Its Total Revenue
  13.3.3 Ennov Solutions Inc Drug Safety and Pharmacovigilance Software Introduction
  13.3.4 Ennov Solutions Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.3.5 Ennov Solutions Inc Recent Development
13.4 ArisGlobal
  13.4.1 ArisGlobal Company Details
  13.4.2 ArisGlobal Business Overview and Its Total Revenue
  13.4.3 ArisGlobal Drug Safety and Pharmacovigilance Software Introduction
  13.4.4 ArisGlobal Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.4.5 ArisGlobal Recent Development
13.5 EXTEDO GmbH
  13.5.1 EXTEDO GmbH Company Details
  13.5.2 EXTEDO GmbH Business Overview and Its Total Revenue
  13.5.3 EXTEDO GmbH Drug Safety and Pharmacovigilance Software Introduction
  13.5.4 EXTEDO GmbH Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.5.5 EXTEDO GmbH Recent Development
13.6 Online Business Applications Inc
  13.6.1 Online Business Applications Inc Company Details
  13.6.2 Online Business Applications Inc Business Overview and Its Total Revenue
  13.6.3 Online Business Applications Inc Drug Safety and Pharmacovigilance Software Introduction
  13.6.4 Online Business Applications Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.6.5 Online Business Applications Inc Recent Development
13.7 Oracle Corporation
  13.7.1 Oracle Corporation Company Details
  13.7.2 Oracle Corporation Business Overview and Its Total Revenue
  13.7.3 Oracle Corporation Drug Safety and Pharmacovigilance Software Introduction
  13.7.4 Oracle Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.7.5 Oracle Corporation Recent Development
13.8 Sparta Systems, Inc.
  13.8.1 Sparta Systems, Inc. Company Details
  13.8.2 Sparta Systems, Inc. Business Overview and Its Total Revenue
  13.8.3 Sparta Systems, Inc. Drug Safety and Pharmacovigilance Software Introduction
  13.8.4 Sparta Systems, Inc. Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.8.5 Sparta Systems, Inc. Recent Development
13.9 United BioSource Corporation
  13.9.1 United BioSource Corporation Company Details
  13.9.2 United BioSource Corporation Business Overview and Its Total Revenue
  13.9.3 United BioSource Corporation Drug Safety and Pharmacovigilance Software Introduction
  13.9.4 United BioSource Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.9.5 United BioSource Corporation Recent Development
13.10 Sarjen Systems
  13.10.1 Sarjen Systems Company Details
  13.10.2 Sarjen Systems Business Overview and Its Total Revenue
  13.10.3 Sarjen Systems Drug Safety and Pharmacovigilance Software Introduction
  13.10.4 Sarjen Systems Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020)
  13.10.5 Sarjen Systems Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Drug Safety and Pharmacovigilance Software Key Market Segments
Table 2. Key Players Covered: Ranking by Drug Safety and Pharmacovigilance Software Revenue
Table 3. Ranking of Global Top Drug Safety and Pharmacovigilance Software Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drug Safety and Pharmacovigilance Software Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ADR Reporting
Table 6. Key Players of Drug Safety Audits
Table 7. Key Players of Issue Tracking
Table 8. Key Players of Fully Integrated Software
Table 9. COVID-19 Impact Global Market: (Four Drug Safety and Pharmacovigilance Software Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Drug Safety and Pharmacovigilance Software Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Drug Safety and Pharmacovigilance Software Players to Combat Covid-19 Impact
Table 14. Global Drug Safety and Pharmacovigilance Software Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Drug Safety and Pharmacovigilance Software Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Drug Safety and Pharmacovigilance Software Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Drug Safety and Pharmacovigilance Software Market Share by Regions (2015-2020)
Table 18. Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Drug Safety and Pharmacovigilance Software Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Drug Safety and Pharmacovigilance Software Market Growth Strategy
Table 24. Main Points Interviewed from Key Drug Safety and Pharmacovigilance Software Players
Table 25. Global Drug Safety and Pharmacovigilance Software Revenue by Players (2015-2020) (Million US$)
Table 26. Global Drug Safety and Pharmacovigilance Software Market Share by Players (2015-2020)
Table 27. Global Top Drug Safety and Pharmacovigilance Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety and Pharmacovigilance Software as of 2019)
Table 28. Global Drug Safety and Pharmacovigilance Software by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Drug Safety and Pharmacovigilance Software Product Solution and Service
Table 31. Date of Enter into Drug Safety and Pharmacovigilance Software Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020) (Million US$)
Table 34. Global Drug Safety and Pharmacovigilance Software Market Size Share by Type (2015-2020)
Table 35. Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Type (2021-2026)
Table 36. Global Drug Safety and Pharmacovigilance Software Market Size Share by Application (2015-2020)
Table 37. Global Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020) (Million US$)
Table 38. Global Drug Safety and Pharmacovigilance Software Market Size Share by Application (2021-2026)
Table 39. North America Key Players Drug Safety and Pharmacovigilance Software Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Drug Safety and Pharmacovigilance Software Market Share (2019-2020)
Table 41. North America Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020) (Million US$)
Table 42. North America Drug Safety and Pharmacovigilance Software Market Share by Type (2015-2020)
Table 43. North America Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020) (Million US$)
Table 44. North America Drug Safety and Pharmacovigilance Software Market Share by Application (2015-2020)
Table 45. Europe Key Players Drug Safety and Pharmacovigilance Software Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Drug Safety and Pharmacovigilance Software Market Share (2019-2020)
Table 47. Europe Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Drug Safety and Pharmacovigilance Software Market Share by Type (2015-2020)
Table 49. Europe Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Drug Safety and Pharmacovigilance Software Market Share by Application (2015-2020)
Table 51. China Key Players Drug Safety and Pharmacovigilance Software Revenue (2019-2020) (Million US$)
Table 52. China Key Players Drug Safety and Pharmacovigilance Software Market Share (2019-2020)
Table 53. China Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020) (Million US$)
Table 54. China Drug Safety and Pharmacovigilance Software Market Share by Type (2015-2020)
Table 55. China Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020) (Million US$)
Table 56. China Drug Safety and Pharmacovigilance Software Market Share by Application (2015-2020)
Table 57. Japan Key Players Drug Safety and Pharmacovigilance Software Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Drug Safety and Pharmacovigilance Software Market Share (2019-2020)
Table 59. Japan Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Drug Safety and Pharmacovigilance Software Market Share by Type (2015-2020)
Table 61. Japan Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Drug Safety and Pharmacovigilance Software Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Drug Safety and Pharmacovigilance Software Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Drug Safety and Pharmacovigilance Software Market Share (2019-2020)
Table 65. Southeast Asia Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Drug Safety and Pharmacovigilance Software Market Share by Type (2015-2020)
Table 67. Southeast Asia Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Drug Safety and Pharmacovigilance Software Market Share by Application (2015-2020)
Table 69. India Key Players Drug Safety and Pharmacovigilance Software Revenue (2019-2020) (Million US$)
Table 70. India Key Players Drug Safety and Pharmacovigilance Software Market Share (2019-2020)
Table 71. India Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020) (Million US$)
Table 72. India Drug Safety and Pharmacovigilance Software Market Share by Type (2015-2020)
Table 73. India Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020) (Million US$)
Table 74. India Drug Safety and Pharmacovigilance Software Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Drug Safety and Pharmacovigilance Software Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Drug Safety and Pharmacovigilance Software Market Share (2019-2020)
Table 77. Central & South America Drug Safety and Pharmacovigilance Software Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Drug Safety and Pharmacovigilance Software Market Share by Type (2015-2020)
Table 79. Central & South America Drug Safety and Pharmacovigilance Software Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Drug Safety and Pharmacovigilance Software Market Share by Application (2015-2020)
Table 81. AB cube Company Details
Table 82. AB cube Business Overview
Table 83. AB cube Product
Table 84. AB cube Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 85. AB cube Recent Development
Table 86. Max Application Company Details
Table 87. Max Application Business Overview
Table 88. Max Application Product
Table 89. Max Application Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 90. Max Application Recent Development
Table 91. Ennov Solutions Inc Company Details
Table 92. Ennov Solutions Inc Business Overview
Table 93. Ennov Solutions Inc Product
Table 94. Ennov Solutions Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 95. Ennov Solutions Inc Recent Development
Table 96. ArisGlobal Company Details
Table 97. ArisGlobal Business Overview
Table 98. ArisGlobal Product
Table 99. ArisGlobal Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 100. ArisGlobal Recent Development
Table 101. EXTEDO GmbH Company Details
Table 102. EXTEDO GmbH Business Overview
Table 103. EXTEDO GmbH Product
Table 104. EXTEDO GmbH Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 105. EXTEDO GmbH Recent Development
Table 106. Online Business Applications Inc Company Details
Table 107. Online Business Applications Inc Business Overview
Table 108. Online Business Applications Inc Product
Table 109. Online Business Applications Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 110. Online Business Applications Inc Recent Development
Table 111. Oracle Corporation Company Details
Table 112. Oracle Corporation Business Overview
Table 113. Oracle Corporation Product
Table 114. Oracle Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 115. Oracle Corporation Recent Development
Table 116. Sparta Systems, Inc. Business Overview
Table 117. Sparta Systems, Inc. Product
Table 118. Sparta Systems, Inc. Company Details
Table 119. Sparta Systems, Inc. Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 120. Sparta Systems, Inc. Recent Development
Table 121. United BioSource Corporation Company Details
Table 122. United BioSource Corporation Business Overview
Table 123. United BioSource Corporation Product
Table 124. United BioSource Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 125. United BioSource Corporation Recent Development
Table 126. Sarjen Systems Company Details
Table 127. Sarjen Systems Business Overview
Table 128. Sarjen Systems Product
Table 129. Sarjen Systems Revenue in Drug Safety and Pharmacovigilance Software Business (2015-2020) (Million US$)
Table 130. Sarjen Systems Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Drug Safety and Pharmacovigilance Software Market Share by Type: 2020 VS 2026
Figure 2. ADR Reporting Features
Figure 3. Drug Safety Audits Features
Figure 4. Issue Tracking Features
Figure 5. Fully Integrated Software Features
Figure 6. Global Drug Safety and Pharmacovigilance Software Market Share by Application: 2020 VS 2026
Figure 7. Pharma & Biotech Companies Case Studies
Figure 8. CROs Case Studies
Figure 9. BPOs Case Studies
Figure 10. Others Case Studies
Figure 11. Drug Safety and Pharmacovigilance Software Report Years Considered
Figure 12. Global Drug Safety and Pharmacovigilance Software Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Drug Safety and Pharmacovigilance Software Market Share by Regions: 2020 VS 2026
Figure 14. Global Drug Safety and Pharmacovigilance Software Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Drug Safety and Pharmacovigilance Software Market Share by Players in 2019
Figure 17. Global Top Drug Safety and Pharmacovigilance Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety and Pharmacovigilance Software as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Drug Safety and Pharmacovigilance Software Revenue in 2019
Figure 19. North America Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. AB cube Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. AB cube Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 28. Max Application Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Max Application Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 30. Ennov Solutions Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Ennov Solutions Inc Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 32. ArisGlobal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. ArisGlobal Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 34. EXTEDO GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. EXTEDO GmbH Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 36. Online Business Applications Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Online Business Applications Inc Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 38. Oracle Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Oracle Corporation Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 40. Sparta Systems, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sparta Systems, Inc. Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 42. United BioSource Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. United BioSource Corporation Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 44. Sarjen Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Sarjen Systems Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed